{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:54:14Z","timestamp":1791219254334,"version":"4.1.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The attenuated strain of Mycobacterium bovis known as bacille Calmette-Gu\u00e9rin (BCG) has been widely used as a vaccine for prevention of disease by Mycobacterium tuberculosis, but with relatively little evidence of success. Recent studies suggest that the failure of BCG may be due to its retention of immune evasion mechanisms that delay or prevent the priming of robust protective cell-mediated immunity. In this study, we describe an approach to enhance the immunogenicity of BCG by incorporating glycolipid activators of CD1d-restricted NKT cells, a conserved T cell subset with the potential to augment many types of immune responses. A method was developed for stably incorporating two forms of the NKT cell activator \u03b1-galactosylceramide into live BCG organisms, and the impact of this on stimulation of T cell responses and protective antimycobacterial immunity was evaluated. We found that live BCG containing relatively small amounts of incorporated \u03b1-galactosylceramide retained the ability to robustly activate NKT cells. Compared with immunization with unmodified BCG, the glycolipid-modified BCG stimulated increased maturation of dendritic cells and markedly augmented the priming of Ag-specific CD8+ T cells responses. These effects were correlated with improved protective effects of vaccination in mice challenged with virulent M. tuberculosis. These results support the view that mycobacteria possess mechanisms to avoid stimulation of CD8+ T cell responses and that such responses contribute significantly to protective immunity against these pathogens. Our findings raise the possibility of a simple modification of BCG that could yield a more effective vaccine for control of tuberculosis.<\/jats:p>","DOI":"10.4049\/jimmunol.0900858","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T19:48:06Z","timestamp":1248119286000},"page":"1644-1656","source":"Crossref","is-referenced-by-count":73,"title":["Incorporation of NKT Cell-Activating Glycolipids Enhances Immunogenicity and Vaccine Efficacy of\n                    <i>Mycobacterium bovis<\/i>\n                    Bacillus Calmette-Gu\u00e9rin"],"prefix":"10.1093","volume":"183","author":[{"given":"Manjunatha M","family":"Venkataswamy","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Baena","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Bricard","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin S","family":"Im","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"},{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye","family":"Reddington","sequence":"additional","affiliation":[{"name":"School of Biosciences, University of Birmingham , Edgbaston, Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurdyal S","family":"Besra","sequence":"additional","affiliation":[{"name":"School of Biosciences, University of Birmingham , Edgbaston, Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William R","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"},{"name":"Howard Hughes Medical Institute, Albert Einstein College of Medicine , Bronx, NY 10461"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A","family":"Porcelli","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"},{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,8,1]]},"reference":[{"key":"2025032619492067700_R1","first-page":"677","article-title":"Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country: WHO Global Surveillance and Monitoring Project.","volume-title":"JAMA","year":"1999"},{"key":"2025032619492067700_R2","first-page":"1255","article-title":"Confronting the scientific obstacles to global control of tuberculosis.","volume-title":"J. Clin. Invest.","year":"2008"},{"key":"2025032619492067700_R3","first-page":"164","article-title":"Tuberculosis vaccine development: goals, immunological design, and evaluation.","volume-title":"Lancet","year":"2008"},{"key":"2025032619492067700_R4","first-page":"484","article-title":"Tuberculosis vaccines: an update.","volume-title":"Nat. Rev. Microbiol.","year":"2007"},{"key":"2025032619492067700_R5","first-page":"2279","article-title":"Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis.","volume-title":"J. Clin. Invest.","year":"2007"},{"key":"2025032619492067700_R6","first-page":"13853","article-title":"Recombinant bacillus Calmette-Gu\u00e9rin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2000"},{"key":"2025032619492067700_R7","first-page":"2472","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin.","volume-title":"J. Clin. Invest.","year":"2005"},{"key":"2025032619492067700_R8","first-page":"271","article-title":"The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice.","volume-title":"J. Exp. Med.","year":"2001"},{"key":"2025032619492067700_R9","first-page":"93","article-title":"Immunology of tuberculosis.","volume-title":"Annu. Rev. Immunol.","year":"2001"},{"key":"2025032619492067700_R10","first-page":"369","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.","volume-title":"Nat. Immunol.","year":"2007"},{"key":"2025032619492067700_R11","first-page":"3689","article-title":"Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells.","volume-title":"Eur. J. Immunol.","year":"2000"},{"key":"2025032619492067700_R12","first-page":"105","article-title":"Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs.","volume-title":"J. Exp. Med.","year":"2008"},{"key":"2025032619492067700_R13","first-page":"2359","article-title":"Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection.","volume-title":"J. Exp. Med.","year":"2008"},{"key":"2025032619492067700_R14","first-page":"297","article-title":"The biology of NKT cells.","volume-title":"Annu. Rev. Immunol.","year":"2007"},{"key":"2025032619492067700_R15","first-page":"1824","article-title":"Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity.","volume-title":"Cell Mol. Life Sci.","year":"2007"},{"key":"2025032619492067700_R16","first-page":"1626","article-title":"CD1d-restricted and TCR-mediated activation of v\u03b114 NKT cells by glycosylceramides.","volume-title":"Science","year":"1997"},{"key":"2025032619492067700_R17","first-page":"987","article-title":"The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.","volume-title":"Int. Immunol.","year":"2000"},{"key":"2025032619492067700_R18","first-page":"1121","article-title":"The natural killer T (NKT) cell ligand \u03b1-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.","volume-title":"J. Exp. Med.","year":"1999"},{"key":"2025032619492067700_R19","first-page":"267","article-title":"Activation of natural killer T cells by \u03b1-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.","volume-title":"J. Exp. Med.","year":"2003"},{"key":"2025032619492067700_R20","first-page":"215","article-title":"CD1-restricted T cells in host defense to infectious diseases.","volume-title":"Curr. Top. Microbiol. Immunol.","year":"2007"},{"key":"2025032619492067700_R21","first-page":"42","article-title":"The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy.","volume-title":"Immunol. Lett.","year":"2005"},{"key":"2025032619492067700_R22","first-page":"1631","article-title":"Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand \u03b1-galactosylceramide.","volume-title":"J. Exp. Med.","year":"2003"},{"key":"2025032619492067700_R23","first-page":"2948","article-title":"CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis.","volume-title":"Infect. Immun.","year":"2000"},{"key":"2025032619492067700_R24","first-page":"519","article-title":"Innate immune response to encephalomyocarditis virus infection mediated by CD1d.","volume-title":"Immunology","year":"2003"},{"key":"2025032619492067700_R25","first-page":"1623","article-title":"Requirement for V\u03b114 NKT cells in IL-12-mediated rejection of tumors.","volume-title":"Science","year":"1997"},{"key":"2025032619492067700_R26","first-page":"1691","article-title":"The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model.","volume-title":"Int. Immunol.","year":"2004"},{"key":"2025032619492067700_R27","first-page":"3383","article-title":"Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of \u03b1-galactosylceramides.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2005"},{"key":"2025032619492067700_R28","first-page":"77","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.","volume-title":"J. Immunol. Methods","year":"1999"},{"key":"2025032619492067700_R29","first-page":"1415","article-title":"Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator.","volume-title":"J. Immunol.","year":"2007"},{"key":"2025032619492067700_R30","first-page":"109","article-title":"Requirements for CD1d recognition by human invariant V\u03b124+ CD4\u2212CD8\u2212 T cells.","volume-title":"J. Exp. Med.","year":"1997"},{"key":"2025032619492067700_R31","first-page":"5140","article-title":"NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.","volume-title":"J. Immunol.","year":"2003"},{"key":"2025032619492067700_R32","first-page":"535","article-title":"Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule.","volume-title":"J. Exp. Med.","year":"2005"},{"key":"2025032619492067700_R33","first-page":"1521","article-title":"CD1d-mediated recognition of an \u03b1-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.","volume-title":"J. Exp. Med.","year":"1998"},{"key":"2025032619492067700_R34","first-page":"1750","article-title":"Synthesis and evaluation of an \u03b1-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells.","volume-title":"Chembiochemistry","year":"2006"},{"key":"2025032619492067700_R35","first-page":"763","article-title":"Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black \u00d7 New Zealand White)F1 mice.","volume-title":"J. Immunol.","year":"2005"},{"key":"2025032619492067700_R36","first-page":"843","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.","volume-title":"Nat. Med.","year":"2007"},{"key":"2025032619492067700_R37","first-page":"2661","article-title":"Cutting edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis.","volume-title":"J. Immunol.","year":"2007"},{"key":"2025032619492067700_R38","first-page":"211","article-title":"A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Gu\u00e9rin).","volume-title":"J. Immunol.","year":"2007"},{"key":"2025032619492067700_R39","first-page":"3973","article-title":"Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1.","volume-title":"J. Immunol.","year":"2007"},{"key":"2025032619492067700_R40","first-page":"977","article-title":"Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells.","volume-title":"Science","year":"1997"},{"key":"2025032619492067700_R41","first-page":"750","article-title":"Mechanism of lipid-body formation in prokaryotes: how bacteria fatten up.","volume-title":"Mol. Microbiol.","year":"2005"},{"key":"2025032619492067700_R42","first-page":"525","article-title":"Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.","volume-title":"Nature","year":"2005"},{"key":"2025032619492067700_R43","first-page":"520","article-title":"Recognition of bacterial glycosphingolipids by natural killer T cells.","volume-title":"Nature","year":"2005"},{"key":"2025032619492067700_R44","first-page":"978","article-title":"Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.","volume-title":"Nat. Immunol.","year":"2006"},{"key":"2025032619492067700_R45","first-page":"28","article-title":"Harnessing invariant NKT cells in vaccination strategies.","volume-title":"Nat. Rev. Immunol.","year":"2009"},{"key":"2025032619492067700_R46","first-page":"1800","article-title":"Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.","volume-title":"J. Clin. Invest.","year":"2004"},{"key":"2025032619492067700_R47","first-page":"617","article-title":"Natural killer T cell ligand \u03b1-galactosylceramide enhances protective immunity induced by malaria vaccines.","volume-title":"J. Exp. Med.","year":"2002"},{"key":"2025032619492067700_R48","first-page":"5189","article-title":"A single intranasal immunization with inactivated influenza virus and \u03b1-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system.","volume-title":"Vaccine","year":"2007"},{"key":"2025032619492067700_R49","first-page":"1807","article-title":"Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, \u03b1-galactosylceramide.","volume-title":"Vaccine","year":"2008"},{"key":"2025032619492067700_R50","first-page":"706","article-title":"Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania.","volume-title":"Eur. J. Immunol.","year":"2008"},{"key":"2025032619492067700_R51","first-page":"10685","article-title":"Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2004"},{"key":"2025032619492067700_R52","first-page":"1230","article-title":"Mechanism of CD1d-restricted natural killer T cell activation during microbial infection.","volume-title":"Nat. Immunol.","year":"2003"},{"key":"2025032619492067700_R53","first-page":"e1000239","article-title":"Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-\u03b3, and kill intracellular bacteria.","volume-title":"PLoS Pathog.","year":"2008"},{"key":"2025032619492067700_R54","first-page":"2292","article-title":"Rapid NKT cell responses are self-terminating during the course of microbial infection.","volume-title":"J. Immunol.","year":"2008"},{"key":"2025032619492067700_R55","first-page":"1973","article-title":"Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis.","volume-title":"J. Exp. Med.","year":"1999"},{"key":"2025032619492067700_R56","first-page":"4204","article-title":"Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2000"},{"key":"2025032619492067700_R57","first-page":"207","article-title":"Minimal contribution of V\u03b114 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice.","volume-title":"Microbiol. Immunol.","year":"2002"},{"key":"2025032619492067700_R58","first-page":"97","article-title":"Mycobacterial infection in natural killer T cell knockout mice.","volume-title":"Tuberculosis","year":"2002"},{"key":"2025032619492067700_R59","first-page":"6302","article-title":"Activation of NKT cells protects mice from tuberculosis.","volume-title":"Infect. Immun.","year":"2002"},{"key":"2025032619492067700_R60","first-page":"3092","article-title":"NKT cell stimulation with glycolipid antigen in vivo: Costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.","volume-title":"J. Immunol.","year":"2005"},{"key":"2025032619492067700_R61","first-page":"105","article-title":"Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.","volume-title":"Immunity","year":"2006"},{"key":"2025032619492067700_R62","first-page":"1190","article-title":"Direct interferon-\u03b3 signaling dramatically enhances CD4+ and CD8+ T cell memory.","volume-title":"J. Immunol.","year":"2007"},{"key":"2025032619492067700_R63","first-page":"107","article-title":"Differential antigen processing by dendritic cell subsets in vivo.","volume-title":"Science","year":"2007"},{"key":"2025032619492067700_R64","first-page":"1095","article-title":"A subset of dendritic cells induces CD4+ T cells to produce IFN-\u03b3 by an IL-12-independent but CD70-dependent mechanism in vivo.","volume-title":"J. Exp. Med.","year":"2007"},{"key":"2025032619492067700_R65","first-page":"4615","article-title":"Invariant NKT cells promote CD8+ cytotoxic T cell responses by inducing CD70 expression on dendritic cells.","volume-title":"J. Immunol.","year":"2008"},{"key":"2025032619492067700_R66","first-page":"888","article-title":"Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.","volume-title":"Immunity.","year":"2009"},{"key":"2025032619492067700_R67","first-page":"350","article-title":"Immunization with dendritic cells loaded with \u03b1-galactosylceramide at priming phase, but not at boosting phase, enhances cytotoxic T lymphocyte activity against infection by intracellular bacteria.","volume-title":"FEMS Immunol. Med. Microbiol.","year":"2007"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/183\/3\/1644\/62696208\/9459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/183\/3\/1644\/62696208\/9459.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T15:24:58Z","timestamp":1743261898000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/183\/3\/1644\/8053935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.0900858","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.719460336.793546293","asserted-by":"object"}]},"ISSN":["1550-6606","0022-1767"],"issn-type":[{"value":"1550-6606","type":"electronic"},{"value":"0022-1767","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,8]]},"published":{"date-parts":[[2009,8,1]]}}}